Managing Tardive Dyskinesia: New Data from Phase 3 Study of Ingrezza

Check out new data from phase 3 study of Ingrezza for the real-world management of tardive dyskinesia.

Related Keywords

Eiryw Roberts ,Neurocrine Biosciences ,Goodideas Adobestock ,Neurocrine Bioscience ,Abnormal Involuntary Movement Scale ,Drug Administration ,Health Psychol Res ,Patient Global Impression ,Clinical Global Impression ,Ingrezza Sprinkle ,Health Psychol ,